Search research articles
Contact Us
Filters
Showing results (141-150 of 221) with videos related to
Page
of 23
Sort By:
Expert Review of Cardiovascular Therapy
|
October 24, 2013
Torsades de pointes following clarithromycin treatment
Michael Gysel, W Victor R Vieweg, Mehrul Hasnain, et al.
European Journal of Medical Genetics
|
March 3, 2017
Long QT syndrome and left ventricular noncompaction in 4 family members across 2 generations with KCNQ1 mutation
Mira Kharbanda, Amanda Hunter, Stephen Tennant, et al.
Biochemical and Biophysical Research Communications
|
October 24, 2006
hERG K+ channel blockade by the antipsychotic drug thioridazine: An obligatory role for the S6 helix residue F656
James T Milnes, Harry J Witchel, Joanne L Leaney, et al.
Biochimica Et Biophysica Acta
|
July 23, 2011
The hERG K(+) channel S4 domain L532P mutation: characterization at 37°C
Yi H Zhang, Charlotte K Colenso, Richard B Sessions, et al.
Cellular and Molecular Life Sciences : CMLS
|
November 28, 2024
Stereoselective block of the hERG potassium channel by the Class Ia antiarrhythmic drug disopyramide
Yihong Zhang, Aziza El Harchi, Andrew F James, et al.
European Journal of Pharmacology
|
July 3, 2007
Differential pharmacology of the cardiac anionic background current I(AB)
John J Borg, Jules C Hancox, Henggui Zhang, et al.
Therapeutic Advances in Drug Safety
|
August 25, 2015
hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes
Jules C Hancox, Dario Melgari, Christopher E Dempsey, et al.
Journal of Molecular and Cellular Cardiology
|
July 31, 2022
Improved Ca<sup>2+</sup> release synchrony following selective modification of I<sub>tof</sub> and phase 1 repolarization in normal and failing ventricular myocytes
Ewan D Fowler, Nan Wang, Melanie J Hezzell, et al.
Journal of Molecular and Cellular Cardiology
|
November 25, 2021
Inducing I<sub>to,f</sub> and phase 1 repolarization of the cardiac action potential with a Kv4.3/KChIP2.1 bicistronic transgene
Nan Wang, Eef Dries, Ewan D Fowler, et al.
The Journal of Physiology
|
April 18, 2012
Pro-arrhythmogenic effects of the S140G KCNQ1 mutation in human atrial fibrillation - insights from modelling
Sanjay Kharche, Ismail Adeniran, Jonathan Stott, et al.
Page
of 23
Search research articles
Search
Showing results (141-150 of 221) with videos related to
Sort By:
Page
of 23
Expert Review of Cardiovascular Therapy
|
October 24, 2013
Torsades de pointes following clarithromycin treatment
Michael Gysel, W Victor R Vieweg, Mehrul Hasnain, et al.
European Journal of Medical Genetics
|
March 3, 2017
Long QT syndrome and left ventricular noncompaction in 4 family members across 2 generations with KCNQ1 mutation
Mira Kharbanda, Amanda Hunter, Stephen Tennant, et al.
Biochemical and Biophysical Research Communications
|
October 24, 2006
hERG K+ channel blockade by the antipsychotic drug thioridazine: An obligatory role for the S6 helix residue F656
James T Milnes, Harry J Witchel, Joanne L Leaney, et al.
Biochimica Et Biophysica Acta
|
July 23, 2011
The hERG K(+) channel S4 domain L532P mutation: characterization at 37°C
Yi H Zhang, Charlotte K Colenso, Richard B Sessions, et al.
Cellular and Molecular Life Sciences : CMLS
|
November 28, 2024
Stereoselective block of the hERG potassium channel by the Class Ia antiarrhythmic drug disopyramide
Yihong Zhang, Aziza El Harchi, Andrew F James, et al.
European Journal of Pharmacology
|
July 3, 2007
Differential pharmacology of the cardiac anionic background current I(AB)
John J Borg, Jules C Hancox, Henggui Zhang, et al.
Therapeutic Advances in Drug Safety
|
August 25, 2015
hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes
Jules C Hancox, Dario Melgari, Christopher E Dempsey, et al.
Journal of Molecular and Cellular Cardiology
|
July 31, 2022
Improved Ca<sup>2+</sup> release synchrony following selective modification of I<sub>tof</sub> and phase 1 repolarization in normal and failing ventricular myocytes
Ewan D Fowler, Nan Wang, Melanie J Hezzell, et al.
Journal of Molecular and Cellular Cardiology
|
November 25, 2021
Inducing I<sub>to,f</sub> and phase 1 repolarization of the cardiac action potential with a Kv4.3/KChIP2.1 bicistronic transgene
Nan Wang, Eef Dries, Ewan D Fowler, et al.
The Journal of Physiology
|
April 18, 2012
Pro-arrhythmogenic effects of the S140G KCNQ1 mutation in human atrial fibrillation - insights from modelling
Sanjay Kharche, Ismail Adeniran, Jonathan Stott, et al.
Page
of 23